Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease

This randomized clinical trial compares the efficacy of a treat-to-target low-density lipoprotein cholesterol (LDL-C) strategy of 50 to 70 mg/dL as the goal vs high-intensity statin therapy for the 3-year composite of death, myocardial infarction, stroke, or coronary revascularization in patients with coronary artery disease.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research